Position in FATE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$164
-$49 QoQ
Shares Held
61
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#150
of 155 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $11,720 across 3 Biotechnology names. FATE ranks #3 (1.4% of the industry book) .
All Filings in FATE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164 | 61 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $213 | 61 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $200 | 61 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $447 | 61 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $228 | 61 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $129 | 61 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $290 | 61 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $615 | 61 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,367 | 61 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,511 | 61 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,024 | 78 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,569 | 61 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,615 | 61 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,294 | 61 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,029 | 61 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,274 | 91 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||